Accelerating Medical Innovation
To Enhance Patient Wellbeing
PBC Biomed was founded in 2010 to drive innovation in Medical Devices, Biomaterials and Pharmaceuticals by helping clients accelerate the commercialization of ideas. Our extensive industry expertise has made us the trusted strategic partner for small to large companies, physicians, universities and government-funded projects to advance the development of life-changing medical technologies.
A Partner you can Trust.
We are passionate about our advancing MedTech, and the impact we can make on patients lives by accelerating innovation within this space.
We take pride in our ability to provide the best resources, technical capabilities and quality of work, by utilising our extensive expertise in the Design, Development and Commercialisation of innovative medical technologies.
PBC Biomed is certified to both ISO 9001,2015 for the provision of Consultancy Services and ISO 13485, 2016 for Design. Development and Manufacture of Bone Substitute materials.
Upcoming Events
CSO Ger Insley to speak at Bioceramics 33
Our CSO Gerard Insley will be discussing advances in Octacalcium Phosphate at the Bioceramics 33 event this October in…
Orthopaedic Trauma Association (OTA)
Come see the PBC BioMed team at the 2023 OTA meeting in Settle this October,…
NASS 2023 – North American Spine Society
The PBC BioMed team will be co-exhibiting with engineering partner Lizard Health at the 2023 NASS Annual Meeting in Los Angeles, this October.
News & Publications
-
PBC Biomed Sponsor GMMDC Leadership Update & Reception
Brittney Martinez, VP of Business Development and Marketing, is pictured speaking on PBC Biomed’s ‘Mission in Memphis’ at the Greater Memphis Medical Device Council (GMMDC) Leadership Update and Reception on August 22nd. The Executive Committee of the Board also provided an update on the strategic direction of the GMMDC and introduced the new Executive Director…
-
PBC Biomed announces opening of Memphis office
PBC BioMed, a medical device design and development company headquartered in Shannon, Ireland, today announced that it will open first U.S. office in Memphis, TN. The PBC BioMed Leadership team, Gerard Insley, Chief Science Officer, Dr. Thomas Russell, Chief Medical Officer, and Brittney Martinez, VP of Business Development and Marketing, were on-site this week for…
-
PBC BioMed announces launch of new innovation management tool ‘AIM’
With an established track record of innovation, PBC BioMed has assembled a global team with a deep understanding of the regulatory, quality, clinical and commercial requirements facing innovators based in the EU or US, and wishing to enter new markets.
-
Collaboration with Curasan AG on Musculoskeletal Regeneration
Shannon, Ireland, 8 June, 2021: PBC Biomed, an Irish-based Medical Device Company, have entered a partnership agreement with Curasan AG, a German-headquartered Medical Device company with global distribution, to develop innovative products in the field of musculoskeletal regeneration. This collaboration will bring together two pioneers in the advancement of biomimetic technologies to create an expanded…
-
Clare FM interview re PBC BioMed / I-Form Osstic medical advance
Gerard Insley, Clare FM interview re PBC BioMed / I-Form Osstic medical advance I-Form · Z0000521
-
PBC Biomed to Lead Consortium in Development of Bone Adhesive
PBC Biomed_Our Why.mp4 SHANNON, Ireland, May 04, 2021 (GLOBE NEWSWIRE) — PBC Biomed, an Irish-based Medical Device Company, will lead a consortium comprised of Biodesign Europe and SFI Research Centre for Advanced Manufacturing (I-Form) at Dublin City University and Dolmen Design & Innovation, a Dublin-based product design company, in developing a bone adhesive for…
-
Tánaiste Leo Varadkar Annouces Funding for 29 projects, including PBC
Tánaiste Leo Varadkar and Ministers Simon Harris and Robert Troy have announced the 29 projects which have secured €95m under #DTIF Call 3. These cover areas such as life sciences, medical devices, ICT, artificial intelligence, manufacturing & environmental sustainability. Tánaiste @LeoVaradkar, and Ministers @SimonHarrisTD and @RobertTroyTD have announced the 29 projects which have secured €95m…
-
Collaboration by RCSI, MTU and PBC for Degenerative Bone Disease Solution
RCSI, MTU and PBC BioMed to collaborate on degenerative bone disease solution RCSI University of Medicine and Health Sciences, Munster Technological University and Irish SME, PBC BioMed are to collaborate on a medical device to address the degenerative bone disease, avascular necrosis. The project is supported by an Enterprise Ireland Innovation Partnership and will develop…
Our Trusted Partners
